Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

NORADRENALINE IMPURITY D CRS (15 MG)

NORADRENALINE IMPURITY D CRS (15 MG)

NA

DISCOVER
NORADRENALINE IMPURITY E CRS (15 MG)

NORADRENALINE IMPURITY E CRS (15 MG)

99-40-1

DISCOVER
PHENYLEPHRINE HYDROCHLORIDE FOR PEAK IDENTIFICATION CRS (2.0

PHENYLEPHRINE HYDROCHLORIDE FOR PEAK IDENTIFICATION CRS (2.0

61-76-7

DISCOVER
Trimethoprim for system suitability CRS, 0.00075mg

Trimethoprim for system suitability CRS, 0.00075mg

738-70-5

DISCOVER
LETROZOLE CRS (80 MG)

LETROZOLE CRS (80 MG)

112809-51-5

DISCOVER
NORADRENALINE IMPURITY F CRS (10 MG)

NORADRENALINE IMPURITY F CRS (10 MG)

20455-68-9

DISCOVER
ALVERINE CITRATE CRS (5 MG)

ALVERINE CITRATE CRS (5 MG)

5560-59-8

DISCOVER
LORATADINE CRS (60 MG)

LORATADINE CRS (60 MG)

79794-75-5

DISCOVER
MYCOPLASMA SYNOVIAE BRP (1 ML)

MYCOPLASMA SYNOVIAE BRP (1 ML)

ND

DISCOVER
MYCOPLASMA HYORHINIS BRP (1 ML)

MYCOPLASMA HYORHINIS BRP (1 ML)

ND

DISCOVER
MYCOPLASMA ORALE BRP (1 ML)

MYCOPLASMA ORALE BRP (1 ML)

ND

DISCOVER
MYCOPLASMA FERMENTANS BRP (1 ML)

MYCOPLASMA FERMENTANS BRP (1 ML)

ND

DISCOVER